Advertisement

Topics

Cyprotex Discovery Ltd Company Profile

14:25 EST 21st November 2017 | BioPortfolio


News Articles [238 Associated News Articles listed on BioPortfolio]

Evotec announces its intent to acquire Cyprotex PLC

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that it has made an offer to acquire Cyprotex PLC ("Cyprotex", AIM: CRX-GB), a specialist pre-clinical contract re...

Cyprotex opens new US lab

Macclesfield-based Cyprotex, which provides outsourced services to pharmaceutical companies, has expanded in the US.The company, a specialist in ADME (absorption, distribution, metabolism, and excre...

Cyprotex Breaks Through with 3D Microtissues

Drug analysis specialist Cyprotex has launched a new “in vitro” service which is able to accurately identify drugs which cause structural damage to the heart.It service combines state of...

Cyprotex invests for new markets at Alderley Park

Cyprotex, the Macclesfield-based drug analysis specialist, is investing in its new space at the BioHub at Alderley Park.In a stock market statement it said it was expanding its bioanalytical capabil...

Cyprotex to Expand Cosmetics Testing with US Deal

Cyprotex, the drug analysis specialist, is paying around £650,000 for CeeTox which carries out toxicology tests on cosmetics and other personal care products.The US-based business is being acq...

Record year for Cyprotex

Contract research organisation Cyprotex has hailed a record year with turnover nearing the £10m-mark.The Macclesfield-based business has posted revenue of £9.8m for the year to 31 Decembe...

US acquisition for Cyprotex

Macclesfield-based Cyprotex has acquired a business in the US. The contract research organisation has purchased the business and assets of CeeTox Inc, a division of North American Science Associates ...

Cyprotex returns to operational profit

Macclesfield-headquartered drug researcher Cyprotex has returned to operational profit following a significant investment in its testing services in 2014. The company, which specialises in research ...

PubMed Articles [563 Associated PubMed Articles listed on BioPortfolio]

Protac-induced Protein Degradation in Drug Discovery: Breaking the Rules - or Just Making New Ones?

Targeted protein degradation, using bifunctional small molecules (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer the...

The Utility of Target-Based Discovery.

18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT.

To evaluate if the new Discovery Molecular Insights (DMI) PET/CT scanner provides equivalent results compared to the standard of care PET/CT scanners (GE Discovery 600 or GE Discovery 690) used in our...

Three-Dimensional Cell Culture: A Rapidly Emerging Approach to Cellular Science and Drug Discovery.

From machine learning to deep learning: progress in machine intelligence for rational drug discovery.

Machine intelligence, which is normally presented as artificial intelligence, refers to the intelligence exhibited by computers. In the history of rational drug discovery, various machine intelligence...

Clinical Trials [146 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [1066 Associated Companies listed on BioPortfolio]

Cyprotex Discovery Ltd

Cyprotex

Cyprotex, founded in April 1999, became an independent privately owned company in June 2000 and we were admitted onto the Alternative Investment Market of the London Stock Exchange in February 2002 (C...

Cyprotex PLC

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and ...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successfu...

More Information about "Cyprotex Discovery Ltd" on BioPortfolio

We have published hundreds of Cyprotex Discovery Ltd news stories on BioPortfolio along with dozens of Cyprotex Discovery Ltd Clinical Trials and PubMed Articles about Cyprotex Discovery Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cyprotex Discovery Ltd Companies in our database. You can also find out about relevant Cyprotex Discovery Ltd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record